Foletta Mark G's Form 4 filing
Dexcom Inc (DXCM) · filed Jul 17, 2025
- Accession no.
- 0001093557-25-000228
- Filed
- Jul 17, 2025
- Trade date
- Jul 15, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $234.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Foletta Mark GCIK 0001236389 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | Common Stock | SSaleDisposed | −2,742 | $85.17F2 | −$233,536.14 | 53,879 | Indirect | |
| Jul 15, 2025 | Common Stock | SSaleDisposed | −8 | $86.03 | −$688.24 | 53,871 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $84.815 to $85.44. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.